Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer
- Thursday, October 7, 2021, 7:11
- PR Newswire
- Add a comment
BALTIMORE and NEW YORK, Oct. 7, 2021 /PRNewswire/ — Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, announced the appointment of Doug Schenkel as Chief Financial Officer. “I am very excited to…
About the Author
admin has written 21103 stories on this site.